Our results indicate that Src inhibition by PP2 inactivates the Src-YAP-IL6 axis in triple-negative MDA-MB-231 and MDA-MB-468 breast cancer cells and suppresses cell migration, invasion, and viability of these cells (Fig. 3A–D). This evidence concerns the gene IL6 and breast cancer.